The opioid crisis needs our best efforts to reduce the death toll and improve the recovery rates for those with opioid use disorders. In 2013, the Hazelden Betty Ford Foundation launched a program, Comprehensive Opioid Response with the Twelve Steps (COR-12™), to improve upon treatment outcomes for patients with opioid use disorders. We combined robust psychosocial therapies and a Twelve Step, abstinence based orientation with medications.
Dr. Seppala will describe our experience with this program as well as our six-month outcome data. The presentation will include descriptions of our decision making, the focus on long-term treatment and recovery outcomes for people with opioid use disorders and how we integrated medications within a Twelve Step oriented system of care. Hazelden Betty Ford Foundation's response to this crisis will be used as an example of how to use both recovery oriented therapies and addiction science to improve the treatment and outcomes of those with opioid use disorders.
A certificate of completion will be awarded for attending this event. Please note, this event has not been approved for continuing education (CE) credit. The participant is responsible to verify if this activity meets their continuing education board requirements in order to gain credit.
Marv Seppala, MD, is chief medical officer at the Hazelden Betty Ford Foundation, and serves as adjunct assistant professor at the Hazelden Betty Ford Graduate School of Addiction Studies. His responsibilities include overseeing all interdisciplinary clinical practices, maintaining and improving standards of care, and supporting growth strategies for residential and nonresidential addiction treatment programs and services throughout the country.
Seppala attended St. Olaf College in Northfield, Minnesota, and is a graduate of Drake University in Des Moines, Iowa. He obtained his MD at Mayo Medical School in Rochester, Minnesota, serving his residency in psychiatry and a fellowship in addiction at University of Minnesota Hospitals in Minneapolis.